Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster vaccination study in elderly adults previously vaccinated with CoronaVac
RBR-5d758t9Phase 4Not yet recruiting
- Sponsor
- Instituto do Câncer Brasil
- Start
- Sep 2021
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in coronavirus disease 2019 (COVID-19) comparing ChAdOx1-S/nCoV-19 booster with CoronaVac booster (2 arms). Primary endpoints: Safety and Immunogenicity increment. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
ChAdOx1 nCoV-19coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-5d758t9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5d758t9.